The Effects of Tryptophan Depletion on Neural Responses to Emotional Words in Remitted Depression

Biological Psychiatry

Volumn 66, Issue 5, 2009, Pages 441-450

  Roiser, Jonathan P ^a,b,e   Levy, Jamey ^b   Fromm, Stephen J ^b   Nugent, Allison C ^b   Talagala, S Lalith ^c   Hasler, Gregor ^b   Henn, Fritz A ^d   Sahakian, Barbara J ^e,f   Drevets, Wayne C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Acute tryptophan depletion; Affective Go No go (AGNG); depression; emotional processing; functional magnetic resonance imaging (fMRI); serotonin

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HABENULA; HEMODYNAMICS; HUMAN; MAJOR DEPRESSION; MOOD CHANGE; NERVE POTENTIAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; REMISSION; REST; SCORING SYSTEM; SHAM PROCEDURE; SPIN LABELING; STIMULUS; TASK PERFORMANCE; THALAMUS;

ADOLESCENT; ADULT; BRAIN; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; REGIONAL BLOOD FLOW; REMISSION, SPONTANEOUS; SEROTONIN; TRYPTOPHAN;

EID: 68049127793     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.05.002     Document Type: Article

References (62)

1. Booij L., Van der Does A.J., and Riedel W.J. Monoamine depletion in psychiatric and healthy populations: Review. Mol Psychiatry 8 (2003) 951-973
2. Booij L., Van der Does W., Benkelfat C., Bremner J.D., Cowen P.J., Fava M., et al. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 27 (2002) 852-861
3. Ruhe H.G., Mason N.S., and Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Mol Psychiatry 12 (2007) 331-359
4. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47 (1990) 411-418
5. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1999) 322-339
6. Rogers R.D., Tunbridge E.M., Bhagwagar Z., Drevets W.C., Sahakian B.J., and Carter C.S. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28 (2003) 153-162
7. Cools R., Blackwell A., Clark L., Menzies L., Cox S., and Robbins T.W. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30 (2005) 1362-1373
8. Harmer C.J., Rogers R.D., Tunbridge E., Cowen P.J., and Goodwin G.M. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology (Berl) 167 (2003) 411-417
9. Murphy F.C., Smith K.A., Cowen P.J., Robbins T.W., and Sahakian B.J. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) 163 (2002) 42-53
10. Smith K.A., Morris J.S., Friston K.J., Cowen P.J., and Dolan R.J. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 174 (1999) 525-529
11. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61 (2004) 765-773
12. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54 (1997) 364-374
13. Morris J.S., Smith K.A., Cowen P.J., Friston K.J., and Dolan R.J. Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion. Neuroimage 10 (1999) 163-172
14. Roiser J.P., Levy J., Fromm S.J., Wang H., Hasler G., Sahakian B.J., et al. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology 33 (2008) 1992-2006
15. Elliott R., Rubinsztein J.S., Sahakian B.J., and Dolan R.J. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 59 (2002) 597-604
16. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., et al. Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29 (1999) 1307-1321
17. Ongur D., and Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 10 (2000) 206-219
18. Ongur D., Ferry A.T., and Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460 (2003) 425-449
19. Drevets W.C., Price J.L., and Furey M.L. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213 (2008) 93-118
20. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) (2002), Biometrics Research, New York State Psychiatric Institute, New York
21. Neumeister A., Konstantinidis A., Stastny J., Schwarz M.J., Vitouch O., Willeit M., et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59 (2002) 613-620
22. McNair D.M., Lorr M., and Droppleman L.F. Manual: Profile of Mood States (POMS) (1971), Educational & Industrial Testing Service, San Diego
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
24. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
25. Talagala S.L., Ye F.Q., Ledden P.J., and Chesnick S. Whole-brain 3D perfusion MRI at 3.0 T using CASL with a separate labeling coil. Magn Reson Med 52 (2004) 131-140
26. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J Neurosci 12 (1992) 3628-3641
27. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
28. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
29. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 (2003) 1233-1239
30. Haynes P.L., McQuaid J.R., Kelsoe J., Rapaport M., and Gillin J.C. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. J Affect Disord 83 (2004) 253-262
31. O'Reardon J.P., Chopra M.P., Bergan A., Gallop R., DeRubeis R.J., and Crits-Christoph P. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biol Psychiatry 55 (2004) 957-959
32. Harmer C.J. Serotonin and emotional processing: Does it help explain antidepressant drug action?. Neuropharmacology 55 (2008) 1023-1028
33. Drevets W.C., and Raichle M.E. Neuroanatomical circuits in depression: Implications for treatment mechanisms. Psychopharmacol Bull 28 (1992) 261-274
34. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 48 (2000) 813-829
35. Erickson K., Drevets W.C., Clark L., Cannon D.M., Bain E.E., Zarate Jr. C.A., et al. Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Am J Psychiatry 162 (2005) 2171-2173
36. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 72 (1992) 165-229
37. Varnas K., Halldin C., and Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22 (2004) 246-260
38. Middleton F.A., and Strick P.L. Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42 (2000) 183-200
39. Van der Werf Y.D., Witter M.P., and Groenewegen H.J. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 39 (2002) 107-140
40. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., and Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9 (2004) 386-392
41. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: An in-vivo imaging study using PET and [carbonyl-C]WAY-100635. Int J Neuropsychopharmacol 11 (2008) 465-476
42. Cowen P.J. Psychopharmacology of 5-HT(1A) receptors. Nucl Med Biol 27 (2000) 437-439
43. di Pellegrino G., Ciaramelli E., and Ladavas E. The regulation of cognitive control following rostral anterior cingulate cortex lesion in humans. J Cogn Neurosci 19 (2007) 275-286
44. Ridderinkhof K.R., Ullsperger M., Crone E.A., and Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 306 (2004) 443-447
45. Mai J.K., Assheuer J., and Paxinos G. Atlas of the Human Brain. 2nd ed. (2003), Academic Press, San Diego
46. Stern W.C., Johnson A., Bronzino J.D., and Morgane P.J. Neuropharmacology of the afferent projections from the lateral habenula and substantia nigra to the anterior raphe in the rat. Neuropharmacology 20 (1981) 979-989
47. Sutherland R.J. The dorsal diencephalic conduction system: A review of the anatomy and functions of the habenular complex. Neurosci Biobehav Rev 6 (1982) 1-13
48. Sakai K., Salvert D., Touret M., and Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 137 (1977) 11-35
49. Christoph G.R., Leonzio R.J., and Wilcox K.S. Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J Neurosci 6 (1986) 613-619
50. Ji H., and Shepard P.D. Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABA(A) receptor-mediated mechanism. J Neurosci 27 (2007) 6923-6930
51. Ullsperger M., and von Cramon D.Y. Error monitoring using external feedback: Specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging. J Neurosci 23 (2003) 4308-4314
52. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
53. Sartorius A., and Henn F.A. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypotheses 69 (2007) 1305-1308
54. Hikosaka O., Sesack S.R., Lecourtier L., and Shepard P.D. Habenula: Crossroad between the basal ganglia and the limbic system. J Neurosci 28 (2008) 11825-11829
55. Caldecott-Hazard S., Mazziotta J., and Phelps M. Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J Neurosci 8 (1988) 1951-1961
56. Shumake J., Edwards E., and Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res 963 (2003) 274-281
57. Fernstrom J.D., and Wurtman R.J. Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178 (1972) 414-416
58. Wolfe B.E., Metzger E.D., and Jimerson D.C. Comparison of the effects of amino acid mixture and placebo on plasma tryptophan to large neutral amino acid ratio. Life Sci 56 (1995) 1395-1400
59. Merens W., Booij L., Haffmans P.M., and van der Does A.J. The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients. J Psychopharmacol 22 (2008) 653-662
60. Booij L., van der Does A.J., Haffmans P.M., Riedel W.J., Fekkes D., and Blom M.J. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J Psychopharmacol 19 (2005) 267-275
61. Hayward G., Goodwin G.M., Cowen P.J., and Harmer C.J. Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry 57 (2005) 517-524
62. Smith K.A., Fairburn C.G., and Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 349 (1997) 915-919